Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Dyspnea Relief in Advanced COPD
NCT03405090Phase 4Completed
- Start
- Sep 2017
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fentanyl in chronic obstructive pulmonary disease (COPD). Started Sep 2017; status: completed.
02
Drugs
fentanyl
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03405090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405090.